(NATR) Natures Sunshine Products - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 384m USD | Total Return: 47.6% in 12m
Avg Turnover: 2.30M
EPS Trend: 52.6%
Qual. Beats: 0
Rev. Trend: 94.7%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Natures Sunshine Products, Inc. (NATR) is a global health and wellness company specializing in the manufacture and distribution of nutritional supplements, weight management systems, and personal care items. Founded in 1972, the firm operates across major international markets including Asia, Europe, and the Americas, marketing its portfolio under the Natures Sunshine and Synergy WorldWide brands.
The company utilizes an omnichannel distribution strategy centered on a network of independent consultants, a common model in the dietary supplement industry to manage customer acquisition costs. Within the Consumer Staples sector, companies like NATR rely heavily on vertical integration, maintaining internal manufacturing facilities to ensure quality control and regulatory compliance for complex herbal formulations.
Investors can examine historical margin trends and valuation multiples on ValueRay to further assess the companys financial health. Headquartered in Lehi, Utah, the company maintains a diverse product catalog ranging from cardiovascular and digestive health supplements to specialized skincare and essential oils.
- Direct-to-consumer digital transformation drives North American revenue growth and margins
- Expansion of independent consultant network accelerates international sales volume
- Raw material cost fluctuations and supply chain efficiency impact gross margins
- Foreign exchange volatility affects reported earnings from Asian and European markets
| Net Income: 19.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.95 > 1.0 |
| NWC/Revenue: 21.89% < 20% (prev 21.91%; Δ -0.02% < -1%) |
| CFO/TA 0.12 > 3% & CFO 30.9m > Net Income 19.9m |
| Net Debt (-65.1m) to EBITDA (44.5m): -1.46 < 3 |
| Current Ratio: 2.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.9m) vs 12m ago -4.87% < -2% |
| Gross Margin: 72.71% > 18% (prev 0.72%; Δ 7.20k% > 0.5%) |
| Asset Turnover: 190.5% > 50% (prev 180.7%; Δ 9.83% > 0%) |
| Interest Coverage Ratio: 276.3 > 6 (EBITDA TTM 44.5m / Interest Expense TTM 112k) |
| A: 0.41 (Total Current Assets 178.6m - Total Current Liabilities 71.4m) / Total Assets 261.5m |
| B: 0.31 (Retained Earnings 82.0m / Total Assets 261.5m) |
| C: 0.12 (EBIT TTM 30.9m / Avg Total Assets 257.1m) |
| D: 1.77 (Book Value of Equity 166.9m / Total Liabilities 94.5m) |
| Altman-Z'' = 6.38 = AAA |
| DSRI: 1.03 (Receivables 12.5m/11.4m, Revenue 489.8m/456.6m) |
| GMI: 0.99 (GM 72.71% / 71.68%) |
| AQI: 0.98 (AQ_t 0.12 / AQ_t-1 0.12) |
| SGI: 1.07 (Revenue 489.8m / 456.6m) |
| TATA: -0.04 (NI 19.9m - CFO 30.9m) / TA 261.5m) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 21.89 with a total of 111,976 shares traded.
Over the past week, the price has changed by -1.62%,
over one month by -20.20%,
over three months by -20.40% and
over the past year by +47.61%.
Natures Sunshine Products has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy NATR.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 35 | 59.9% |
P/E Trailing = 19.8636
P/E Forward = 17.0358
P/S = 0.7845
P/B = 2.2988
P/EG = 2.0789
Revenue TTM = 489.8m USD
EBIT TTM = 30.9m USD
EBITDA TTM = 44.5m USD
Long Term Debt = 18.1m USD (estimated: total debt 22.4m - short term 4.37m)
Short Term Debt = 4.37m USD (from shortTermDebt, last quarter)
Debt = 22.4m USD (from shortLongTermDebtTotal, last quarter) (leases 22.4m already included)
Net Debt = -65.1m USD (calculated: Debt 22.4m - CCE 87.6m)
Enterprise Value = 319.1m USD (384.2m + Debt 22.4m - CCE 87.6m)
Interest Coverage Ratio = 276.3 (Ebit TTM 30.9m / Interest Expense TTM 112k)
EV/FCF = 13.86x (Enterprise Value 319.1m / FCF TTM 23.0m)
FCF Yield = 7.21% (FCF TTM 23.0m / Enterprise Value 319.1m)
FCF Margin = 4.70% (FCF TTM 23.0m / Revenue TTM 489.8m)
Net Margin = 4.06% (Net Income TTM 19.9m / Revenue TTM 489.8m)
Gross Margin = 72.71% ((Revenue TTM 489.8m - Cost of Revenue TTM 133.7m) / Revenue TTM)
Gross Margin QoQ = 73.22% (prev 72.52%)
Tobins Q-Ratio = 1.22 (Enterprise Value 319.1m / Total Assets 261.5m)
Interest Expense / Debt = 0.50% (Interest Expense 112k / Debt 22.4m)
Taxrate = 37.24% (3.04m / 8.15m)
NOPAT = 19.4m (EBIT 30.9m * (1 - 37.24%))
Current Ratio = 2.50 (Total Current Assets 178.6m / Total Current Liabilities 71.4m)
Debt / Equity = 0.13 (Debt 22.4m / totalStockholderEquity, last quarter 166.9m)
Debt / EBITDA = -1.46 (Net Debt -65.1m / EBITDA 44.5m)
Debt / FCF = -2.83 (Net Debt -65.1m / FCF TTM 23.0m)
Total Stockholder Equity = 161.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.74% (Net Income 19.9m / Total Assets 261.5m)
RoE = 12.30% (Net Income TTM 19.9m / Total Stockholder Equity 161.7m)
RoCE = 17.22% (EBIT 30.9m / Capital Employed (Equity 161.7m + L.T.Debt 18.1m))
RoIC = 18.17% (NOPAT 19.4m / Invested Capital 106.9m)
WACC = 7.59% (E(384.2m)/V(406.7m) * Re(8.01%) + D(22.4m)/V(406.7m) * Rd(0.50%) * (1-Tc(0.37)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.78 | Cagr: -3.43%
[DCF] Terminal Value 77.97% ; FCFF base≈20.7m ; Y1≈23.8m ; Y5≈35.0m
[DCF] Fair Price = 33.65 (EV 526.5m - Net Debt -65.1m = Equity 591.7m / Shares 17.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 52.61 | EPS CAGR: 24.59% | SUE: 0.51 | # QB: 0
Revenue Correlation: 94.72 | Revenue CAGR: 4.12% | SUE: 0.19 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.29 | Chg30d=+0.00% | Revisions=-33% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.37 | Chg30d=+10.45% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=1.28 | Chg30d=+14.29% | Revisions=+0% | GrowthEPS=+1.6% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=1.28 | Chg30d=+3.64% | Revisions=+33% | GrowthEPS=+0.0% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: -33%